NAFLD Diagnostics Advancements Revolutionizing Fibrosis Staging Solutions 2026 The Pivot Away from Invasive Procedures For decades, the standard for assessing the severity and progression of non-alcoholic fatty liver disease, particularly the transition to Non-Alcoholic Steatohepatitis (NASH) and subsequent fibrosis, has relied heavily on the liver biopsy. This invasive procedure carries...